03:23 AM EDT, 06/03/2024 (MT Newswires) -- Amy W Schulman, Director, on May 29, 2024, sold 21,700 shares in Alnylam Pharmaceuticals ( ALNY ) for $3,224,546. Following the Form 4 filing with the SEC, Schulman has control over a total of 8,436 shares of the company, with 8,436 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1178670/000173527624000058/xslF345X03/edgardoc.xml